Condition: Endometriosis · Sponsor: Gesynta Pharma AB
The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
This description comes directly from the study's public registry record.
CMO VP Clinical Development · +46 762 788 389 · ctg@gesynta.se
Always discuss trial participation with your own doctor first.
| MHAT Puls AD | Blagoevgrad, Bulgaria | Recruiting |
| Lyulin Hospital | Sofia, Bulgaria | Recruiting |
| FemiClinic | Sofia, Bulgaria | Recruiting |
| Gynekologie MEDA s.r.o | Brno, Czechia | Recruiting |
| Fakultni nemocnice Brno | Brno, Czechia | Recruiting |
| NEUMED Gynekologicka Ambulance s.r.o. | Olomouc, Czechia | Recruiting |
| Gyncare MUDr. Michael Svec s.r.o. | Pilsen, Czechia | Recruiting |
| STELLA-GYN, s.r.o. | Vodňany, Czechia | Recruiting |
| MedEnd | Budapest, Hungary | Recruiting |
| Semmelweis Egyetem II. Sz. Szuleszeti es Nogyogyaszati Klinika | Budapest, Hungary | Recruiting |
| Robert Karoly Private Hospital Tritonlife Medical Center | Budapest, Hungary | Recruiting |
| Debreceni Egyetem Klinikai Kozpont | Debrecen, Hungary | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07260669